Citadel Advisors - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$501,978
-82.9%
210,915
-86.8%
0.00%
-100.0%
Q1 2023$2,943,717
-14.5%
1,599,846
-11.7%
0.00%0.0%
Q4 2022$3,441,278
+40.7%
1,811,199
+58.5%
0.00%0.0%
Q3 2022$2,445,000
-60.2%
1,142,605
-47.4%
0.00%
-50.0%
Q2 2022$6,148,000
-58.0%
2,172,257
-38.2%
0.00%
-33.3%
Q1 2022$14,647,000
+60.7%
3,512,513
+100.0%
0.00%
+50.0%
Q4 2021$9,115,000
-45.0%
1,756,243
-30.6%
0.00%
-33.3%
Q3 2021$16,586,000
-9.6%
2,532,134
-8.3%
0.00%
-25.0%
Q2 2021$18,344,000
+7575.3%
2,762,754
+6530.2%
0.00%
Q1 2021$239,000
+40.6%
41,669
+119.2%
0.00%
Q4 2020$170,000
+9.0%
19,008
+42.2%
0.00%
Q3 2020$156,000
-98.3%
13,368
-97.7%
0.00%
-100.0%
Q2 2020$9,287,000
+166.5%
579,344
-0.4%
0.00%
+50.0%
Q1 2020$3,485,000
+2192.8%
581,704
+4940.3%
0.00%
Q4 2019$152,000
-86.8%
11,541
-83.8%
0.00%
-100.0%
Q2 2019$1,148,00071,2850.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$49,738,11274.10%
TFG Asset Management GP Ltd 12,000,000$27,960,0005.10%
Paradigm Biocapital Advisors LP 14,406,782$33,567,8022.28%
Lynx1 Capital Management LP 1,363,025$3,175,8482.10%
Deep Track Capital, LP 15,000,000$34,950,0001.35%
Affinity Asset Advisors, LLC 1,992,466$4,642,4461.31%
DAFNA Capital Management LLC 928,253$2,162,8290.67%
Frazier Life Sciences Management, L.P. 3,746,857$8,730,1770.58%
ARMISTICE CAPITAL, LLC 6,900,000$16,077,0000.25%
Blackstone Inc. 20,485,611$47,731,4740.20%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders